Literature DB >> 23788390

Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper: executive summary.

Christian Pristipino1, Gian Paolo Anzola, Luigi Ballerini, Antonio Bartorelli, Moreno Cecconi, Massimo Chessa, Andrea Donti, Achille Gaspardone, Giuseppe Neri, Eustaquio Onorato, Gualtiero Palareti, Serena Rakar, Gianluca Rigatelli, Gennaro Santoro, Danilo Toni, Gian Paolo Ussia, Roberto Violini.   

Abstract

OBJECTIVES: To organize a common approach on the management of patent foramen ovale (PFO) and cryptogenic stroke that may be shared by different specialists.
BACKGROUND: The management of PFO related to cryptogenic stroke is controversial, despite an increase in interventional closure procedures.
METHODS: A consensus statement was developed by approaching Italian national cardiological, neurological, and hematological scientific societies. Task force members were identified by the president and/or the boards of each relevant scientific society or working group, as appropriate. Drafts were outlined by specific task force working groups. To obtain a widespread consensus, these drafts were merged and distributed to the scientific societies for local evaluation and revision by as many experts as possible. The ensuing final draft, merging all the revisions, was reviewed by the task force and finally approved by scientific societies.
RESULTS: Definitions of transient ischemic attack and both symptomatic and asymptomatic cryptogenic strokes were specified. A diagnostic workout was identified for patients with candidate event(s) and patient foramen ovale to define the probable pathogenesis of clinical events and to describe individual PFO characteristics. Further recommendations were provided regarding medical and interventional therapy considering individual risk factors of recurrence. Finally, follow-up evaluation was appraised.
CONCLUSIONS: Available data provided the basis for a shared approach to management of cryptogenic ischemic cerebral events and PFO among different Italian scientific societies. Wider international initiatives on the topic are awaited.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23788390     DOI: 10.1002/ccd.24693

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  10 in total

Review 1.  Closing patent foramen ovale in cryptogenic stroke: The underscored importance of other interatrial shunt variants.

Authors:  Gianluca Rigatelli; Alberto Rigatelli
Journal:  World J Cardiol       Date:  2015-06-26

Review 2.  [Patent foramen ovale-intervention or pharmaceutical treatment].

Authors:  C Liebetrau; C W Hamm
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

3.  A challenging multifactorial migraine with aura.

Authors:  Luca Naldi; Margherita De Stefano; Andrea Berni; Marco Torri; Loredana Poggesi
Journal:  Intern Emerg Med       Date:  2014-01-14       Impact factor: 3.397

4.  ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease : A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons.

Authors:  John U Doherty; Smadar Kort; Roxana Mehran; Paul Schoenhagen; Prem Soman
Journal:  J Nucl Cardiol       Date:  2019-08       Impact factor: 5.952

5.  Transient cerebral ischemia in an elderly patient with patent foramen ovale and atrial septal aneurysm.

Authors:  Alfonso Merante; Pietro Gareri; Alberto Castagna; Norma Maria Marigliano; Mafalda Candigliota; Alessandro Ferraro; Giovanni Ruotolo
Journal:  Clin Interv Aging       Date:  2015-09-07       Impact factor: 4.458

6.  How often is patent foramen ovale an innocent bystander?

Authors:  Francesco Versaci; Giampiero Vizzari; Domenico Sergi; Giuseppe Andò; Antonio Trivisonno; Francesco Romeo
Journal:  Clin Case Rep       Date:  2017-10-26

Review 7.  How to Understand Patent Foramen Ovale Clinical Significance - Part II: Therapeutic Strategies in Cryptogenic Stroke.

Authors:  Gabriella Falanga; Scipione Carerj; Giuseppe Oreto; Bijoy Khandheria; Concetta Zito
Journal:  J Cardiovasc Echogr       Date:  2015 Apr-Jun

Review 8.  How to Understand Patent Foramen Ovale Clinical Significance: Part I.

Authors:  Gabriella Falanga; Scipione Carerj; Giuseppe Oreto; Bijoy K Khandheria; Concetta Zito
Journal:  J Cardiovasc Echogr       Date:  2014 Oct-Dec

9.  Left atrial enlargement as a maker of significant high-risk patent foramen ovale.

Authors:  Gianluca Rigatelli; Marco Zuin; Alessandro Adami; Silvio Aggio; Daniela Lanza; Katia d'Elia; Gabriele Braggion; Monia Russo; Alberto Mazza; Loris Roncon
Journal:  Int J Cardiovasc Imaging       Date:  2019-07-19       Impact factor: 2.357

10.  Multidisciplinary assessment of PFO with substantial right-to-left shunting and medium-term follow-up after PFO device closure: A single-center experience.

Authors:  Lu He; Ge-Sheng Cheng; Ya-Juan Du; Yu-Shun Zhang
Journal:  J Interv Cardiol       Date:  2017-06-01       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.